What is the USPSTF recommendation for osteoporosis screening in postmenopausal women 65 years or older?

What is the USPSTF recommendation for osteoporosis screening in postmenopausal women 65 years or older?

• A. The USPSTF recommends screening for osteoporosis in postmenopausal women 65 years or older.
• B. The USPSTF recommends screening only if prior fracture.
• C. The USPSTF recommends not screening after age 65.
• D. The USPSTF recommends screening only with DEXA if risk factors present.

Answer: (A)

Screening for osteoporosis in postmenopausal women who are 65 years or older is recommended because fracture risk rises with age and loss of bone density accelerates after menopause. The USPSTF endorses using a DXA bone density test to detect osteoporosis in this group so that early interventions—such as calcium and vitamin D, lifestyle modifications, and medications when indicated—can reduce the chance of fractures. This population has a clear, substantial net benefit from screening, which is why universal screening at this age is advised. In younger postmenopausal women, screening is instead guided by individual fracture risk. So the best choice reflects the standard approach of screening all women 65 and older with DXA.

Screening for osteoporosis in postmenopausal women who are 65 years or older is recommended because fracture risk rises with age and loss of bone density accelerates after menopause. The USPSTF endorses using a DXA bone density test to detect osteoporosis in this group so that early interventions—such as calcium and vitamin D, lifestyle modifications, and medications when indicated—can reduce the chance of fractures. This population has a clear, substantial net benefit from screening, which is why universal screening at this age is advised. In younger postmenopausal women, screening is instead guided by individual fracture risk. So the best choice reflects the standard approach of screening all women 65 and older with DXA.